ClinicalTrials.Veeva

Menu

Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients. (COINN)

M

Masaryk University

Status

Enrolling

Conditions

Nutrition Disorders

Treatments

Other: enteral nutrition

Study type

Interventional

Funder types

Other

Identifiers

NCT03573453
CT0012018

Details and patient eligibility

About

The purpose of the study is to compare continuous versus intermittent strategy for enteral nutrition. The study will examine if there is a difference in achieving nutritional delivery goals, tolerance and number of complications of enteral nutrition.

Full description

The study will commence following the Approval by The Ethics Research Committee. All patients admitted to our ICU from the 1st of June 2018 to the 31st of May 2019 will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. Enteral nutrition will be administered via nasogastric of orogastric tube. Patients will be randomised in 2 groups. In the group of patients receiving continuous feeding will be enteral nutrition administered via enteral feeding pump for at least 16 hours par day. In the group of patients receiving intermittent feeding will be enteral nutrition administered as 30-60minutes lasting bolus via enteral feeding pump 6 times per day. Following the administration of the bolus the patient will be placed for 30 minutes in semi-upright sitting position. Enteral nutrition requirement and composition will be standardised with the adoption of international guidelines. In 5 subsequent days from the enteral nutrition commencement will be examined if there is a difference in achieving energy and protein targets, tolerance and number of complications of enteral nutrition in between both groups. As achievement of energy and protein targets will be considered at least 80% of calculated values. The tolerance of enteral nutrition will be evaluated by the clinical examination of the abdomen, presence of diarrhoea, vomiting and the gastric residual volume of at least 0,5 liter. As the complications of enteral nutrition will be regarded the aspiration of gastric contents and ventilator associated pneumonia. Nutritional status parameters will be analysed. the length of hospital stay, ICU length of stay and 28-day mortality will be also monitored.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 18 - 80 years
  • indication of enteral nutrition with nasogastric or orogastric tube
  • Nutrition Risk in the Critically Ill (NUTRIC) score ≥5
  • Body mass index between 18 - 50
  • mechanical ventilation expected for at least 72 hours

Exclusion criteria

  • upper gastrointestinal tract surgery in previous medical history
  • bowel obstruction
  • bowel ischemia
  • acute pancreatitis
  • severe diarrhoea (>1l/24hours)
  • gastrointestinal bleeding
  • short bowel syndrome
  • malabsorption syndrome in previous medical history
  • ongoing enteral nutrition on admission to ICU

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 2 patient groups

Intermittent
Experimental group
Description:
enteral nutrition will be administered via enteral feeding pump as 30-60minutes lasting bolus 6 times per day volume of initial bolus will be 80ml. The volume of bolus will be increased gradually according to tolerance, till the estimated target rate will be reached
Treatment:
Other: enteral nutrition
Continuous
Experimental group
Description:
enteral nutrition will be administered via enteral feeding pump for at least 16 hours par day initial rate will be 25ml/hour. The rate will be increased gradually according to tolerance, till the estimated target rate will be reached
Treatment:
Other: enteral nutrition

Trial contacts and locations

1

Loading...

Central trial contact

Robert Vach, MD; Ondrej Hrdy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems